Email updates

Keep up to date with the latest news and content from Biomarker Research and BioMed Central.

Open Access Highly Accessed Review

New urinary biomarkers for diabetic kidney disease

Cheng Wang, CuiCui Li, WenYu Gong and Tanqi Lou*

Author Affiliations

Division of Nephrology, Department of Medicine, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510630, China

For all author emails, please log on.

Biomarker Research 2013, 1:9  doi:10.1186/2050-7771-1-9

Published: 4 February 2013


Diabetic kidney disease is the leading cause of end-stage renal disease in developed and developing countries. Microalbuminuria is the gold standard for detection and prediction of diabetic kidney disease and cardiovascular risk disease in clinical practice. However, microalbuminuria has several limitations, such as lower sensitive, larger variability. It is urgent to explore higher sensitivity and specificity for earlier detection of diabetic kidney disease and more accurate prediction of the progression to end stage renal disease. We reviewed some new and important urinary biomarkers, such as: transferrin, immunoglobulin G, immunoglobulin M, Cystanic C, podocytes, type IV collagen, 8-oxo-7, 8-dihydro-2'-deoxyguanosine, ceruloplasmin, monocyte chemoattractant protein-1 and so on. We need good quality, long-term, large longitudinal trials to validate published biomarkers and find new biomarkers, considering biomarkers reviewed here are from small cross-sectional studies.

Diabetic kidney disease; Biomarker; Urine